Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 7,834 shares at $21.63 ($169K) on 2023-07-26, disclosed to the SEC on 2023-07-27.
Open-market sale of $169k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.63 | 3,917 | $85K | 50.0% |
| 2 | $21.63 | 3,917 | $85K | 50.0% |
| Total | $21.63 avg | 7,834 | $169K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |